| For: | Li DG, Jiang JP, Chen FY, Wu W, Fu J, Wang GH, Li YB. Insulin-like growth factor 2 targets IGF1R signaling transduction to facilitate metastasis and imatinib resistance in gastrointestinal stromal tumors. World J Gastrointest Oncol 2024; 16(8): 3585-3599 [PMID: 39171181 DOI: 10.4251/wjgo.v16.i8.3585] | 
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i8/3585.htm | 
| Number | Citing Articles | 
| 1 | 
                                            Fang Fang, Rui Tai, Fu Yang, Ran Dong, Yaqing Zhang. Bioinformatic methods uncover 5 diagnostic biomarkers associated with drug resistance and metastasis for gastrointestinal stromal tumor. Current Pharmaceutical Analysis 2025; 21(2): 67 doi: 10.1016/j.cpan.2025.01.003
                                         | 
| 2 | 
                                            Xian-Hao Xiao, Qian-Shi Zhang, Ji-Yuan Hu, Yin-Xu Zhang, He Song. Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance. Pharmaceutics 2025; 17(7): 923 doi: 10.3390/pharmaceutics17070923
                                         | 
| 3 | 
                                            Yanyun Hong, Xiaodong Wang, Chunhui Shou, Xiaosun Liu. Molecular Mechanisms and Clinical Implications of Fibroblast Growth Factor Receptor 2 Signaling in Gastrointestinal Stromal Tumors. Current Issues in Molecular Biology 2025; 47(10): 822 doi: 10.3390/cimb47100822
                                         | 

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        